Cowingene HPV 28 Genotyping Detection Kit (Liquid) - Taizhou Cowingene Biotech Co., Ltd.

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) represents a significant advancement in molecular diagnostics, offering a reliable and efficient method for detecting 28 high-risk human papillomavirus (HPV) subtypes. Developed by Taizhou Cowingene Biotech Co., Ltd., this kit is designed to support early detection and risk assessment for cervical cancer and other HPV-related conditions. This article provides a detailed analysis of the product's features, technical specifications, applications, and the company's commitment to innovation in diagnostic technologies.

Product Overview

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) is a molecular diagnostic tool that utilizes polymerase chain reaction (PCR) technology to identify 28 specific HPV genotypes. The kit is validated for use with multiple specimen types, including cervical swabs, urine, and self-collected vaginal samples, making it a versatile solution for clinical laboratories and healthcare providers.

Image: Read More About human papilloma virus hpv pcr

Key Features and Advantages

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) offers several distinct advantages that make it a preferred choice for HPV testing:

• High Sensitivity and Specificity: The kit employs advanced PCR technology to ensure accurate detection of even low viral loads, minimizing the risk of false negatives and false positives.
• Comprehensive Genotype Coverage: It targets 28 high-risk HPV subtypes, including 16, 18, 31, 33, 35, 39, 45, 51, 52, 53, 56, 58, 59, 66, 68, 73, and 81, among others, providing a broad spectrum of coverage for clinical decision-making.
• Flexible Sample Types: The kit is validated for use with cervical swabs, urine, and self-collected vaginal samples, accommodating diverse patient populations and reducing the need for invasive procedures.
• User-Friendly Workflow: The liquid-based detection system simplifies the testing process, reducing hands-on time and improving laboratory efficiency.
• Compliance with Industry Standards: The product aligns with international diagnostic standards, ensuring reliability and consistency in results.

Image: Read More About human papillomavirus pcr

Technical Specifications

Parameter	Details
Tested HPV Subtypes	16, 18, 26, 31, 33, 35, 39, 40, 42, 43, 44, 45, 51, 52, 53, 55, 56, 58, 59, 61, 66, 68, 73, 81, 82, 83
Validated Specimens	Cervical swab, Urine, Self-collected vaginal
Technology	PCR-based genotyping
Sample Preparation	Automated or manual extraction (depending on laboratory setup)
Turnaround Time	Approximately 3-4 hours from sample preparation to result generation
Storage Conditions	2-8°C for reagents; -20°C for long-term storage of samples
Kit Components	PCR master mix, primers, controls, and reagents for 28 HPV subtypes

Image: Read More About hpv detection by pcr

Applications in Clinical and Research Settings

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) is widely applicable in both clinical and research environments:

• Cervical Cancer Screening: The kit enables the identification of high-risk HPV subtypes associated with cervical cancer, allowing for early intervention and personalized treatment plans.
• Public Health Surveillance: By detecting multiple HPV genotypes, the kit supports epidemiological studies to monitor the prevalence and distribution of HPV in different populations.
• Research and Development: The product's comprehensive genotype coverage makes it a valuable tool for studying HPV pathogenesis, vaccine efficacy, and the development of novel diagnostic methods.
• Point-of-Care Testing: The kit's flexibility with self-collected samples facilitates decentralized testing, particularly in resource-limited settings where access to traditional cervical swabs may be challenging.

Company Background: Taizhou Cowingene Biotech Co., Ltd.

Taizhou Cowingene Biotech Co., Ltd. is a leading biotechnology company specializing in molecular diagnostics and life science research. With a focus on innovation and quality, the company develops cutting-edge solutions for infectious disease detection, genetic testing, and cancer diagnostics. Cowingene's commitment to scientific excellence is reflected in its rigorous validation processes and adherence to international standards.

As highlighted by the National Institute of Standards and Technology (NIST), "Accurate and reliable diagnostic tools are essential for advancing public health and ensuring the safety of medical technologies" (NIST, 2025). Cowingene's HPV 28 Genotyping Detection Kit exemplifies this principle by providing a standardized, high-performance solution for HPV testing.

Conclusion

The Cowingene HPV 28 Genotyping Detection Kit (Liquid) stands out as a robust and versatile diagnostic tool for HPV detection. Its comprehensive genotype coverage, user-friendly design, and flexibility with sample types make it an invaluable asset for clinical laboratories and research institutions. By partnering with Taizhou Cowingene Biotech Co., Ltd., healthcare providers can ensure accurate and reliable results, contributing to improved patient outcomes and public health initiatives.

References

NIST (National Institute of Standards and Technology). (2025). https://www.nist.gov

Cowingene Biotech Co., Ltd. (2025). https://www.cowingene.com